GURU.Markets stock price, segment price, and overall market index valuation
The company's share price ASP Isotopes Inc.
Shares of ASP Isotopes, a company involved in isotope enrichment, are a speculative bet on future demand for these materials in medicine and nuclear energy. Their price is driven by news about technological developments and contract awards, rather than current financial performance.
Share prices of companies in the market segment - Chemistry
ASP Isotopes (ASPI) is a company engaged in the development and production of isotopes, specifically the enriched isotope silicon-28, which has applications in quantum computing and other advanced industries. We classify it as a "Chemistry" company. The chart below shows the dynamics of this highly specialized, science-intensive sector.
Broad Market Index - GURU.Markets
ASP Isotopes is a company that enriches isotopes such as Carbon-14 and Molybdenum-100 for use in medicine and industry. As a component of the GURU.Markets index, it operates in a unique sector. The chart below represents the entire market. See how this company's stock compares to the overall trend.
Change in the price of a company, segment, and market as a whole per day
ASPI - Daily change in the company's share price ASP Isotopes Inc.
The volatility of ASP Isotopes, an isotope enrichment company, reflects speculative interest in niche technologies. Change_co measures extreme sensitivity to contract news. This parameter is important for formulas on System.GURU.Markets that analyze early-stage companies with unique technologies.
Daily change in the price of a set of shares in a market segment - Chemistry
The chemical sector in which ASP Isotopes Inc. operates is highly dynamic. This chart reflects the industry's average volatility. It serves as a benchmark for assessing how sensitive ASP's isotope enrichment business is to overall trends and demand from the medical and nuclear energy sectors.
Daily change in the price of a broad market stock, index - GURU.Markets
ASP Isotopes is a nuclear technology company specializing in isotopes. This sector is innovative but also highly volatile, driven by expectations of technological breakthroughs and significant risks. The chart below reflects these fluctuations, serving as a barometer for ASP stock valuation.
Dynamics of market capitalization of the company, segment and the market as a whole over 12 months
Annual dynamics of the company's market capitalization ASP Isotopes Inc.
ASP Isotopes is a company operating in the chemical industry. Its shares are sensitive to commodity prices and the state of the global economy. This fundamental cyclical volatility is an important component of the overall economic picture that influences the market.
Annual dynamics of market capitalization of the market segment - Chemistry
ASP Isotopes, as an isotope enrichment company, operates in a high-tech and strategically important niche. The success of such companies depends on their unique technologies and long-term contracts. Its dynamics will be distinct from the broader chemical sector, reflecting the specificities of the nuclear and medical industries.
Annual dynamics of market capitalization of broad market stocks, index - GURU.Markets
ASP Isotopes is a highly speculative bet on the future of nuclear energy and medicine. Its stock price performance since its IPO has nothing to do with the economy, but is driven by news about the company's development and ability to produce rare isotopes. The chart reflects investors' faith in this breakthrough technology.
Dynamics of market capitalization of the company, segment and the market as a whole for the month
Monthly dynamics of the company's market capitalization ASP Isotopes Inc.
As a nuclear technology company, ASP Isotopes' market capitalization will be speculative. Monthly fluctuations on the chart will reflect not revenue, but rather news about progress in the production of enriched isotopes for medicine and energy, which will determine its future.
Monthly dynamics of market capitalization of the market segment - Chemistry
ASP Isotopes is a company specializing in the production of enriched isotopes for use in a variety of industries, from medicine (cancer diagnostics and treatment) to future technologies such as quantum computing. The chart below reflects the dynamics in the chemical sector, where ASP occupies an ultra-niche position.
Monthly dynamics of market capitalization of broad market stocks, index - GURU.Markets
ASP Isotopes Inc. enriches isotopes for use in various industries, including medicine and nuclear energy. It is a unique and high-tech business. The company's share price performance depends on long-term contracts and end-market developments, rather than on general market trends.
Dynamics of market capitalization of the company, segment and the market as a whole for the week
Weekly dynamics of the company's market capitalization ASP Isotopes Inc.
Shares of ASP Isotopes, a company that enriches isotopes for various industries, experience high volatility on a weekly basis. News of contracts in nuclear medicine or nuclear energy, as well as technological breakthroughs in enrichment, trigger sharp price movements.
Weekly dynamics of market capitalization of the market segment - Chemistry
ASP Isotopes and the entire nuclear technology sector are moving against a backdrop of news about the "green" agenda and demand from the medical sector. Investor sentiment toward nuclear energy and nuclear medicine is creating high volatility for everyone.
Weekly dynamics of market capitalization of stocks of the broad market, index - GURU.Markets
ASP Isotopes, a speculative tech startup, is a high-beta asset. Its shares can soar on general market optimism, but plummet at the slightest fear. The chart clearly demonstrates this exaggerated tracking of market sentiment.
Market capitalization of the company, segment and market as a whole
ASPI - Market capitalization of the company ASP Isotopes Inc.
ASP Isotopes' market capitalization is the financial valuation of a company seeking to become a supplier of enriched isotopes for healthcare and clean energy. The chart reflects investor confidence in its technology and potential in these strategically important markets. Its speculative dynamics tell a story about how the market values ββa science-intensive business at an early stage of development.
ASPI - Share of the company's market capitalization ASP Isotopes Inc. within the market segment - Chemistry
ASP Isotopes is a company that enriches isotopes, specifically silicon-28, for use in quantum computing and other high-tech applications. Its market share in the chemical/technology sector is based on this unique and strategically important product. The chart shows its potential in the industry of the future.
Market capitalization of the market segment - Chemistry
ASP Isotopes is a company specializing in the production of enriched isotopes for medical and industrial use. The chart below shows the overall market capitalization of the chemical sector. Within this sector, ASP occupies a unique and high-tech niche where precision and purity are crucial.
Market capitalization of all companies included in a broad market index - GURU.Markets
The nuclear technologies visible in the chart have applications in medicine and industry. ASP Isotopes Inc. enriches isotopes used in nuclear medicine and energy. Its market capitalization is a bet on its unique technologies and the growing demand for specialized isotopes.
Book value capitalization of the company, segment and market as a whole
ASPI - Book value capitalization of the company ASP Isotopes Inc.
The ASP Isotopes chart represents capital for the production of rare isotopes. The book value reflects investments in the development and construction of enrichment facilities for isotopes such as molybdenum-100, which are critical for nuclear medicine and other high-tech industries.
ASPI - Share of the company's book capitalization ASP Isotopes Inc. within the market segment - Chemistry
ASP Isotopes Inc. is building a unique production base. Its share of the sector's assets reflects investments in isotope enrichment plants for medical and industrial applications. The company is creating capital-intensive and technologically sophisticated physical infrastructure for a highly niche market.
Market segment balance sheet capitalization - Chemistry
ASP Isotopes is engaged in isotope enrichment. Nuclear energy, as the chart shows, is extremely capital-intensive. ASP is building plants that will produce rare isotopes for medical and industrial applications, which is a capital-intensive business.
Book value of all companies included in the broad market index - GURU.Markets
ASP Isotopes Inc. is a company engaged in isotope enrichment for use in various industries, from medicine to nuclear energy. Its book value comes from its investment in the development and construction of centrifuges for this high-tech process.
The ratio of market capitalization to book capitalization of a company, segment, and the market as a whole
Market capitalization to book capitalization ratio - ASP Isotopes Inc.
ASP Isotopes is a technology company. Its entire market capitalization represents a premium to its modest assets, betting on its ability to establish commercial production of rare isotopes for medical and energy applications.
Market to book capitalization ratio in a market segment - Chemistry
ASP Isotopes enriches isotopes used in medicine and industry, including nuclear energy. It's a high-tech, niche business. The chart shows how the market values ββits unique technologies and potential in strategically important markets.
Market to book capitalization ratio for the market as a whole
ASP Isotopes is a company that enriches isotopes such as Uranium-235 for use in nuclear energy and medicine. Compared to average market valuations shown in the chart, its high premium is speculative and is based on the potential of its advanced enrichment technology and growing demand for nuclear materials.
Debts of the company, segment and market as a whole
ASPI - Company debts ASP Isotopes Inc.
ASP Isotopes is a company specializing in the production of enriched isotopes for medical and industrial use. This process requires complex and expensive equipment. This chart likely reflects how the company is raising capital to build and launch its production facilities to enter this high-tech and niche market.
Market segment debts - Chemistry
ASP Isotopes enriches isotopes for use in various industries, including medicine and nuclear energy. This is a high-tech and capital-intensive process. This chart shows how the company is funding the creation and expansion of its production facilities.
Market debt in general
Debt to book value of the company, segment and market as a whole
The company's debt to book capitalization ratio ASP Isotopes Inc.
ASP Isotopes Inc. produces isotopes for medical and industrial use. This chart shows how the company finances its production facility at an early stage. Debt at this stage is an indicator of risk and the lenders' faith in the technology, but success will depend on the ability to establish commercial supplies.
Market segment debt to market segment book capitalization - Chemistry
ASP Isotopes is a company that enriches isotopes for use in various industries, including medicine and nuclear energy. This is a high-tech and capital-intensive operation. This chart shows the overall debt burden in the chemical and scientific industries. It provides insight into how the company finances its unique and expensive production processes.
Debt to book value of all companies in the market
ASP Isotopes Inc. produces isotopes for use in healthcare and technology. This is a high-tech and capital-intensive operation. This chart provides context for assessing the company's financial strategy: how it uses capital to build and operate its enrichment facilities, and whether its debt load is justified by the potential of its unique products.
P/E of the company, segment and market as a whole
P/E - ASP Isotopes Inc.
This chart for ASP Isotopes, a company producing enriched isotopes, shows the valuation of a unique high-tech business. The price-to-earnings ratio will reflect demand for its products in areas such as medical diagnostics and quantum computing. This is a bet that its rare materials will become key to future technologies.
P/E of the market segment - Chemistry
ASP Isotopes is a pre-sale company that enriches isotopes such as Carbon-14 and Molybdenum-100 for use in the healthcare and technology industries. This chart shows the average valuation for the chemical industry, helping to understand how the market views this high-tech and capital-intensive niche.
P/E of the market as a whole
ASP Isotopes enriches isotopes, specifically silicon for the semiconductor industry and isotopes for nuclear medicine. Its valuation is a bet on future demand for these high-tech materials. It is not tied to the general economic cycles reflected here, but depends on technological breakthroughs in quantum computing and medicine.
Future P/E of the company, segment and market as a whole
Future (projected) P/E of the company ASP Isotopes Inc.
ASP Isotopes is a company that enriches isotopes, specifically silicon-28, which can be used in quantum computing, and other isotopes for medicine and energy. This chart reflects long-term, speculative market expectations regarding future breakthroughs in quantum technologies and demand for specialized isotopes.
Future (projected) P/E of the market segment - Chemistry
ASP Isotopes Inc. is a company engaged in the production and enrichment of isotopes such as Uranium-235 and Molybdenum-100 for use in nuclear energy and nuclear medicine. This chart shows general expectations for the chemical sector. The ASPI's position relative to the average reflects how the market assesses the prospects and risks of this high-tech and strategically important business.
Future (projected) P/E of the market as a whole
ASP Isotopes Inc. enriches isotopes for medical and industrial use. It's a highly specialized and knowledge-intensive business. This overall risk appetite chart is important because companies with such unique yet complex technologies often require the support of investors committed to long-term growth.
Profit of the company, segment and market as a whole
Company profit ASP Isotopes Inc.
ASP Isotopes Inc. is a company engaged in isotope enrichment, specifically silicon-28, which is used in quantum computing, and molybdenum-100 for medical purposes. Its financials reflect the early stages of development; future profitability depends on the ability to establish commercial production and find markets.
Profit of companies in the market segment - Chemistry
ASP Isotopes Inc. enriches isotopes, specifically silicon-28, which can be used in quantum computing, as well as other isotopes for medical and industrial applications. This chart illustrates the overall financial performance of the chemical sector. It helps assess the macroeconomic trends facing the entire industry, including its high-tech niches.
Overall market profit
ASP Isotopes Inc. is a company engaged in the production and enrichment of isotopes for medical and industrial use, specifically silicon isotopes for quantum computers. This is a high-tech niche whose growth depends on scientific breakthroughs rather than general economic cycles. However, the positive backdrop seen in this chart is helping attract capital for production development.
Future (predicted) profit of the company, segment and market as a whole
Future (projected) profit of the company ASP Isotopes Inc.
ASP Isotopes Inc. is a company producing enriched isotopes for use in medicine (e.g., cancer diagnostics) and technology. Future profits depend on the ability to establish commercial production. This chart reflects analysts' expectations for growth in demand for these high-tech materials across various industries.
Future (predicted) profit of companies in the market segment - Chemistry
ASP Isotopes is a company specializing in isotope enrichment, specifically silicon-28, which has potential for use in quantum computing, as well as isotopes for medical applications. The company's future depends on the development of these cutting-edge technologies. This chart shows forecasts for the chemical industry, providing context for assessing ASP Isotopes' high-tech niche.
Future (predicted) profit of the market as a whole
ASP Isotopes Inc. enriches isotopes for various industries, including medicine and nuclear energy. Demand in these sectors is often driven by long-term technological trends and regulations, rather than the short-term economic cycles shown in this chart.
P/S of the company, segment and market as a whole
P/S - ASP Isotopes Inc.
ASP Isotopes is a company that enriches isotopes for use in various industries, including medicine and nuclear energy. Being in the early stages, it has a high valuation. This chart reflects investors' confidence in its proprietary technology and the future demand for specialized isotopes, such as those used in cancer treatment.
P/S market segment - Chemistry
ASP Isotopes Inc. is a company engaged in the production and enrichment of isotopes used in medicine, nuclear energy, and industry. Future revenue is dependent on the launch of production facilities. This chart for the chemical and nuclear industries reflects investor expectations for ASP Isotopes' potential to carve out a niche in this strategically important market.
P/S of the market as a whole
ASP Isotopes is a company developing and producing isotopes, specifically enriched silicon-28, which can be used to create more efficient quantum computers. This market valuation chart helps us understand the enormous expectations investors have for the company, whose products could become a key component of future technologies.
Future P/S of the company, segment and market as a whole
Future (projected) P/S of the company ASP Isotopes Inc.
ASP Isotopes is a company specializing in the production and enrichment of isotopes such as Carbon-14 and Molybdenum-100, which are used in medicine, industry, and science. This chart shows how investors estimate the future sales of these high-tech materials. It reflects expectations for growing demand for nuclear medicine and other advanced technologies.
Future (projected) P/S of the market segment - Chemistry
ASP Isotopes is a development-stage company that uses the aerodynamic separation process (ASP) to produce enriched isotopes for various industries, including medicine (e.g., cancer treatment) and nuclear energy. The company's valuation is based on investors' belief in the potential of its technology to produce scarce and valuable isotopes.
Future (projected) P/S of the market as a whole
ASP Isotopes Inc. produces isotopes used in nuclear medicine, healthcare, and technology. The company operates in a highly specialized but critical market. In the overall revenue growth picture illustrated by the chart, ASPI represents the high-tech, science-intensive sector.
Sales of the company, segment and market as a whole
Company sales ASP Isotopes Inc.
ASP Isotopes enriches isotopes for medical and industrial use. Being in the development stage, the company does not yet have significant commercial revenue. Any revenue that may be reflected in the graph is likely related to initial supply contracts or government research grants.
Sales of companies in the market segment - Chemistry
ASP Isotopes (ASPI) is a company developing and producing isotopes, specifically enriched silicon-28, which is crucial for quantum computing. This chart shows revenues in the chemical industry, where ASPI's advanced technologies could play a key role in creating the next generation of ultra-powerful computers and medical isotopes.
Overall market sales
ASP Isotopes enriches isotopes, particularly molybdenum-100, which is used in medical diagnostics. Demand for its products depends on the development of nuclear medicine. This general economic activity influences public and private healthcare spending, which, in turn, determines investment in advanced diagnostic technologies.
Future sales volume of the company, segment and market as a whole
Future (projected) sales of the company ASP Isotopes Inc.
ASP Isotopes is a company developing and producing isotopes such as enriched silicon-28, which can be used to create more efficient semiconductors. Future revenue depends on the commercialization of this technology. This chart reflects analyst forecasts, which are betting on a technological breakthrough in the semiconductor industry thanks to their products.
Future (projected) sales of companies in the market segment - Chemistry
ASP Isotopes is a company engaged in the production and enrichment of isotopes for use in various industries, including medicine and nuclear energy. The forecast in this chart reflects potential future revenue from the sale of these high-tech materials. This is an analyst's view of isotope demand in global markets.
Future (projected) sales of the market as a whole
ASP Isotopes is a company that enriches isotopes such as Carbon-14 and Silicon-28 for use in medicine, technology, and green energy. Their business is in the early stages. This schedule, reflecting the investment climate, impacts the availability of capital for the construction of their future production facilities and commercialization.
Marginality of the company, segment and market as a whole
Company marginality ASP Isotopes Inc.
ASP Isotopes Inc. enriches isotopes such as Carbon-14 and Molybdenum-100, which are used in medicine and industry. While in the process of building its production facilities, the company incurs significant expenses. The chart shows the current profitability, which represents an investment in creating a unique, high-tech facility with significant potential.
Market segment marginality - Chemistry
ASP Isotopes is a company developing and producing enriched isotopes for use in healthcare and clean energy, such as silicon isotopes for quantum computers. This chart reflects its operating expenses at the development stage. Future profitability depends on the successful commercialization of this cutting-edge technology.
Market marginality as a whole
ASP Isotopes Inc. enriches isotopes used in a variety of industries, from medicine to nuclear energy. It's a high-tech and capital-intensive business. This overall profitability chart reflects the status of its potential customers. Growth in relevant industries drives demand for the specialized products ASP manufactures.
Employees in the company, segment and market as a whole
Number of employees in the company ASP Isotopes Inc.
ASP Isotopes is a company specializing in isotope enrichment for use in various industries, including medicine and nuclear energy. During the development phase, its team will grow as production facilities are built and launched. This schedule will be a key indicator of the transition from development to commercial production.
Share of the company's employees ASP Isotopes Inc. within the market segment - Chemistry
ASP Isotopes is a company specializing in the production of enriched isotopes for medical and industrial use. This is a high-tech, niche production process. This graph illustrates that working in such an advanced field requires a relatively small but highly skilled team of scientists and engineers.
Number of employees in the market segment - Chemistry
ASP Isotopes Inc. enriches isotopes, particularly molybdenum-100, for use in medicine and other industries. This chart, showing employment in the chemical industry, provides a very general overview. For ASPI, the key demand is for medical isotopes for diagnostics, which is growing as the population ages and nuclear medicine advances.
Number of employees in the market as a whole
ASP Isotopes produces enriched isotopes for use in advanced technologies, including healthcare and nuclear energy. Its highly specialized production requires a unique workforce. It is building a business to supply critical materials for future industries, as shown here.
Market capitalization per employee (in thousands of dollars) of the company, segment, and market as a whole
Market capitalization per employee (in thousands of dollars) of the company ASP Isotopes Inc. (ASPI)
ASP Isotopes is a company engaged in the production and enrichment of isotopes for medical and industrial use. This is a high-tech and capital-intensive operation. This chart shows how the market values ββthe company's unique technologies and potential in niche but critical markets, which creates a high cost per employee.
Market capitalization per employee (in thousands of dollars) in the market segment - Chemistry
ASP Isotopes is a company engaged in the production and enrichment of isotopes for use in medicine and industry. It is a high-tech, niche business. Its high market capitalization per employee may reflect the value of its unique technologies and growth potential in specialized markets, such as nuclear medicine.
Market capitalization per employee (in thousands of dollars) for the overall market
ASP Isotopes is a company engaged in isotope enrichment for various markets, including healthcare and nuclear energy. The chart reflects the valuation of a company with a unique and technologically complex technology. Its high cost per employee is driven by the potential of its developments and the high value of the final product, not by headcount.
Profit per employee (in thousands of dollars) for the company, segment, and market as a whole
Profit per employee (in thousands of dollars) of the company ASP Isotopes Inc. (ASPI)
ASP Isotopes (ASPI) is a company that enriches isotopes, specifically silicon isotopes for semiconductors and molybdenum-100 for medical applications. This is a high-tech, capital-intensive operation. This chart demonstrates how their patented enrichment technology is efficient and profitable, even with a relatively small staff of scientists and operators.
Profit per employee (in thousands of dollars) in the market segment - Chemistry
ASP Isotopes (ASPI) is a company engaged in isotope enrichment, specifically Molybdenum-100 (for medical purposes) and Silicon-28 (for quantum computers). This is a highly scientific and capital-intensive R&D/manufacturing process. At this stage, this figure reflects the investment in developing this complex technology.
Profit per employee (in thousands of dollars) for the market as a whole
ASP Isotopes Inc. is a company that enriches isotopes, specifically silicon-28 (for quantum computers) and molybdenum-100 (for medicine). This is a high-tech, knowledge-intensive, and capital-intensive operation. This chart is important for understanding that in the deep tech sector, employees are the cost center, creating a unique and potentially very expensive product.
Sales to employees of the company, segment and market as a whole
Sales per company employee ASP Isotopes Inc. (ASPI)
ASP Isotopes is a company specializing in the production of enriched isotopes for use in healthcare and technology. Being in the development stage, it may not have significant revenue. The chart will reflect the initial commercialization stage, showing how the company begins to supply its high-value materials for various advanced applications.
Sales per employee in the market segment - Chemistry
ASP Isotopes (ASPI) is a company engaged in the enrichment and production of isotopes used in medicine (diagnostics) and industry (e.g., semiconductors). This chart shows the average revenue per employee in the segment. It helps assess how effectively ASPI utilizes its personnel and technology to produce valuable materials.
Sales per employee for the market as a whole
ASP Isotopes (ASPI) is a company developing isotope enrichment technologies, specifically silicon isotopes for semiconductors and uranium isotopes for nuclear energy. This is a highly scientific and capital-intensive R&D project. Currently, the company likely has no revenue. This near-zero figure reflects the investment in the team of scientists and engineers working on this breakthrough technology.
Short shares by company, segment and market as a whole
Shares shorted by company ASP Isotopes Inc. (ASPI)
ASP Isotopes (ASPI) is a company involved in isotope enrichment, specifically silicon isotopes for semiconductors and molybdenum-100 for medical applications. It's an extremely niche and technologically complex business. This chart shows short interest. The high short interest reflects the speculative nature of the company, the risks associated with scaling its enrichment technology, and uncertain demand. (347)
Shares shorted by market segment - Chemistry
ASP Isotopes is an early-stage company seeking to produce enriched isotopes (such as molybdenum-100) for nuclear medicine and energy. This chart reflects the overall sentiment in the sector, reflecting investor skepticism toward venture capital-backed technologies in the nuclear industry.
Shares shorted by the overall market
ASP Isotopes (ASPI) is a company that enriches isotopes, specifically silicon isotopes for semiconductors and molybdenum-100 for nuclear medicine. It's a very niche and knowledge-intensive business. This chart shows the odds against their technology. Bears may doubt the company will be able to establish commercial production of these rare materials or that there will be insufficient demand for them.
RSI 14 indicator for a company, segment, and market as a whole
The company's RSI 14 indicator ASP Isotopes Inc. (ASPI)
ASP Isotopes is an R&D company working on isotope enrichment. This is a highly speculative bet on future technology. An ASPI above 70 could reflect hype or news of progress. Below 30 signals doubts about the technology, delays, or general risk aversion, indicating panic.
RSI 14 Market Segment - Chemistry
ASP Isotopes (ASPI) is a company working on enriching *isotopes* (for example, silicon-28 for quantum chips). RSI_14_Seg for their segment (specialty chemicals/quantum) shows the "temperature." It helps us understand: is ASPI's volatility a result of their unique technology or the general "hype" in the sector?
RSI 14 for the overall market
ASP Isotopes is a pure bet on the "future" (nuclear medicine). This chart is its lifeline. During periods of market euphoria, investors are willing to generously fund unprofitable but breakthrough R&D projects. In moments of panic, the money supply is turned off, and investors flee speculative ventures, demanding profits.
Analyst consensus forecast for the company's share price, the segment, and the market as a whole
Analyst consensus stock price forecast ASPI (ASP Isotopes Inc.)
ASP Isotopes (ASPI) is a company involved in isotope enrichment, particularly molybdenum-100, which is critical for nuclear medicine. This chart shows the average target price. It reflects analysts' assessment of the company's ability to establish commercial production and demand from the nuclear medicine sector.
The difference between the consensus estimate and the actual stock price ASPI (ASP Isotopes Inc.)
ASP Isotopes is a company developing isotope enrichment technologies, specifically silicon isotopes (for quantum computers) and molybdenum isotopes (for medical purposes). This chart illustrates the analyst community's opinion on the company's future. It measures the distance between the current price and the consensus target price, demonstrating whether experts believe in these high-tech markets.
Analyst consensus forecast for stock prices by market segment - Chemistry
ASP Isotopes is a high-tech company producing enriched stable isotopes (such as Molybdenum-100), which are critical for nuclear medicine (diagnostics and cancer treatment). This chart shows analysts' overall expectations for the entire chemical sector. It reflects whether experts believe the medical isotope market will grow.
Analysts' consensus forecast for the overall market share price
ASP Isotopes is a company focused on isotope enrichment, specifically silicon isotopes for quantum computers and uranium isotopes for nuclear energy. These are deep technologies. This chart shows overall market sentiment. For ASPI, a venture capital firm that trades in the future, it's important to understand how these expectations (risk appetite) influence the funding of their capital-intensive R&D. (348)
AKIMA index of the company, segment and market as a whole
AKiMA Company Index ASP Isotopes Inc.
ASP Isotopes (ASPI) is a pre-revenue company focused on producing enriched isotopes (uranium and molybdenum) for two markets: nuclear energy (HALEU fuel) and nuclear medicine. This chart represents pure R&D investment. Its valuation reflects the market's confidence in their proprietary enrichment technology (ACR) and the strategic importance of their future products.
AKIMA Market Segment Index - Chemistry
ASP Isotopes (ASPI) is a speculative R&D project; the company is trying to develop a new isotope enrichment technology (for nuclear medicine and nuclear energy). This comprehensive index evaluates companies. The chart shows the sector average. This is a benchmark: how does this futuristic (R&D) bet (ASPI) differentiate it from the average competitor?
The AKIM Index for the overall market
ASP Isotopes is a company developing isotope enrichment technologies for medicine, nuclear energy, and industrial applications. This chart, reflecting the market average, provides background information. It helps assess how ASPI, a niche technology player in the critical materials supply chain, fits into the overall macroeconomic picture.